• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰化酶表型与系统性红斑狼疮之间缺乏关联的进一步证据。

Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosus.

作者信息

Baer A N, Woosley R L, Pincus T

出版信息

Arthritis Rheum. 1986 Apr;29(4):508-14. doi: 10.1002/art.1780290408.

DOI:10.1002/art.1780290408
PMID:3707628
Abstract

An association between host acetylator phenotype and idiopathic systemic lupus erythematosus (SLE) has been sought for over a decade, without a definitive result. We have observed that the frequency of the slow acetylator phenotype was similar in 64 patients with idiopathic SLE (38%), 60 healthy volunteers (50%), and 52 non-SLE medical service patients (44%). The slow acetylator phenotype was not more frequent among subgroups of the SLE patients defined by demographic features or specific manifestations of disease. Our results, as well as a majority of previously published results, do not provide evidence for an association between acetylator phenotype and idiopathic SLE.

摘要

十多年来,人们一直在探寻宿主乙酰化酶表型与特发性系统性红斑狼疮(SLE)之间的关联,但尚无明确结果。我们观察到,64例特发性SLE患者(38%)、60名健康志愿者(50%)和52名非SLE内科患者(44%)中慢乙酰化酶表型的频率相似。慢乙酰化酶表型在根据人口统计学特征或疾病特定表现定义的SLE患者亚组中并不更常见。我们的结果以及大多数先前发表的结果均未提供乙酰化酶表型与特发性SLE之间存在关联的证据。

相似文献

1
Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosus.乙酰化酶表型与系统性红斑狼疮之间缺乏关联的进一步证据。
Arthritis Rheum. 1986 Apr;29(4):508-14. doi: 10.1002/art.1780290408.
2
Acetylator phenotype in idiopathic systemic lupus erythematosus.特发性系统性红斑狼疮中的乙酰化酶表型
Arthritis Rheum. 1980 May;23(5):569-73. doi: 10.1002/art.1780230508.
3
Normal distribution of acetylation phenotypes in systemic lupus erythematosus.系统性红斑狼疮中乙酰化表型的正态分布。
Arthritis Rheum. 1978 Mar;21(2):192-5. doi: 10.1002/art.1780210203.
4
Acetylator phenotype in Iraqi patients with systemic lupus erythematosus.伊拉克系统性红斑狼疮患者的乙酰化酶表型
East Mediterr Health J. 2005 Sep-Nov;11(5-6):1003-8.
5
The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a South-east Asian population: a study of Indians, Malays and Malaysian Chinese.东南亚人群中乙酰化酶表型与特发性系统性红斑狼疮之间不存在关联:一项针对印度人、马来人和马来西亚华人的研究。
Br J Rheumatol. 1990 Dec;29(6):462-4. doi: 10.1093/rheumatology/29.6.462.
6
Acetylator phenotype in systemic lupus erythematosus.系统性红斑狼疮中的乙酰化酶表型
Arthritis Rheum. 1977 Apr;20(3):815-8. doi: 10.1002/art.1780200309.
7
Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.异烟肼代谢、日本特发性系统性红斑狼疮患者与对照受试者的异烟肼表型分析方法比较及乙酰化酶分布
Br J Clin Pharmacol. 1982 Mar;13(3):361-74. doi: 10.1111/j.1365-2125.1982.tb01387.x.
8
Drug acetylation and expression of lupus erythematosus.药物乙酰化与红斑狼疮的表达
Eur J Clin Pharmacol. 1985;28(4):387-90. doi: 10.1007/BF00544355.
9
No demonstrable relationship between IgM and IgG antinuclear antibody levels and acetylator phenotype in patients with systemic lupus erythematosus.系统性红斑狼疮患者中IgM和IgG抗核抗体水平与乙酰化酶表型之间无明显关联。
Arthritis Rheum. 1985 Sep;28(9):995-8. doi: 10.1002/art.1780280906.
10
Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus.药物乙酰化表型与自发性系统性红斑狼疮的发生无关。
Arthritis Rheum. 1979 Jul;22(7):777-80. doi: 10.1002/art.1780220714.

引用本文的文献

1
Genotype-Guided Hydralazine Therapy.基因型指导下的肼屈嗪治疗。
Am J Nephrol. 2020;51(10):764-776. doi: 10.1159/000510433. Epub 2020 Sep 14.
2
Acetylator polymorphism in discoid lupus erythematosus.盘状红斑狼疮中的乙酰化酶多态性
Eur J Clin Pharmacol. 1988;34(3):307-8. doi: 10.1007/BF00540961.